Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated

Qianqian Zhang1,2, Sijin Cheng1, Yongzhi Wang3,4

  • 1State Key Laboratory of Brain and Cognitive Science, CAS Center for Excellence in Brain Science and Intelligence Technology, Institute of Brain-Intelligence Technology (Shanghai), Bioland Laboratory (Guangzhou), Institute of Biophysics, Chinese Academy of Sciences, 100101, Beijing, China.

Nature Communications
|November 26, 2021
PubMed

Insights

Spinal ependymomas involve diverse tumor-associated macrophage (TAM) subsets influencing tumor growth and immune response. Understanding these TAMs offers new avenues for targeted immunotherapies against spinal cord tumors.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Single-cell genomics

Background:

  • Spinal ependymomas are common adult spinal cord tumors.
  • Intratumoral cellular heterogeneity and microglial roles in spinal ependymomas remain understudied.

Purpose of the Study:

  • To dissect the microenvironmental landscape of spinal ependymomas using single-cell RNA-sequencing.
  • To investigate the involvement and functional phenotypes of spinal microglia and tumor-associated macrophages (TAMs) in tumor progression.

Main Methods:

  • Single-cell RNA-sequencing (scRNA-seq) analysis of three spinal ependymoma subtypes.
  • Single-cell ATAC-sequencing (scATAC-seq) data analysis.
  • Cell-cell interaction assessment.

Main Results:

  • Identified distinct tumor-associated macrophage (TAM) subsets: CCL2+ TAMs involved in immune response and apoptosis, and CD44+ TAMs associated with tumor angiogenesis.
  • Revealed roles of TEAD1 and EGR3 in regulating TAM functional diversity.
  • Characterized diverse features of malignant cells and TAMs correlating with varying malignant degrees.
  • Demonstrated that stromal cells mediate TAM diversity via extracellular factors.

Conclusions:

  • Spinal ependymomas exhibit complex microenvironments with diverse TAM subsets playing dual roles in tumor progression.
  • Findings provide valuable insights for developing TAM-targeting immunotherapies for spinal cord tumors.